浙矿股份：拟4.06亿元收购哈萨克斯坦铅银矿 公司拟通过控股子公司海南长兴使用现金 35,000 万坚戈（折合人民币约488.53 万元）购买 TKS 公司持有的 Alaigyr 公司的 100%股 权，以及TKS 公司持有 Alaigyr 公司的股东借款，债务金额不低于 2,876,945.42 万坚戈（折合人民币约 40,156.41 万元）。最终收购 价款将根据后续审计、评估及交割日标的公司资产负债表的情况确定。 Alaigyr 公司持有的核心资产为位于哈萨克斯坦卡拉干达州的铅银矿。 | 转债代码 | 转债名称 | 类型 | 日期 | 公告 | | --- | --- | --- | --- | --- | | 127080 | 声迅转债 | 不下修 | 2026-01-06 | 公告 | | 118020 | 芳源转债 | 提议下修 | 2026-01-06 | 公告 | | 118004 | XD博瑞转 | 不强赎 | 2026-01-06 | 公告 | | 转债代码 | 转债名称 | 现价 | 强赎价 | 最后交易日 | 最后转股日 | 转股价值 | 剩余规模 | 转债占正股 | | --- | ...

转债代码：118004 转债简称：博瑞转债 博瑞生物医药（苏州）股份有限公司 登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688166 证券简称：博瑞医药（维权） 公告编号：2025-105 关于"博瑞转债"2025年付息的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 博瑞生物医药（苏州）股份有限公司（以下简称"公司"）于2022年1月4日发行的可转换公司债券将于 2026年1月5日（因2026年1月4日为非交易日，故顺延至下一个交易日）开始支付自2025年1月4日至2026 年1月3日期间的利息。根据《博瑞生物医药（苏州）股份有限公司向不特定对象发行可转换公司债券募 集说明书》（以下简称"《可转债募集说明书》"）有关条款的规定，现将有关事项公告如下： 一、可转债发行上市概况 经中国证券监督管理委员会证监许可[2021]3551号文同意注册，公司于2022年1月4日向不特定对象发行 465万张可转换公司债券，每张面值为人民币100元，发行总额46,500.00万元。本次发行的可转换公 ...

格隆汇12月25日丨博瑞医药(688166.SH)公布，公司于2022年1月4日发行的可转换公司债券将于2026年1 月5日（因2026年1月4日为非交易日，故顺延至下一个交易日）开始支付自2025年1月4日至2026年1月3 日期间的利息。 责任编辑：钟离 财经频道更多独家策划、专家专栏，免费查阅>> 本次付息为"博瑞转债"第四年付息，计息期间为2025年1月4日至2026年1月3日。本计息年度票面利率为 1.5%（含税），即每手"博瑞转债"（面值1000元）兑息金额为15元人民币（含税）。 ...

本次付息为"博瑞转债"第四年付息，计息期间为2025年1月4日至2026年1月3日。本计息年度票面利率为 1.5%（含税），即每手"博瑞转债"（面值1000元）兑息金额为15元人民币（含税）。 格隆汇12月25日丨博瑞医药(688166.SH)公布，公司于2022年1月4日发行的可转换公司债券将于2026年1 月5日（因2026年1月4日为非交易日，故顺延至下一个交易日）开始支付自2025年1月4日至2026年1月3 日期间的利息。 ...

Core Viewpoint - The China Convertible Bond Index rose by 0.39% on December 19, reaching 485.31 points, indicating a positive trend in the convertible bond market [1][2] Group 1: Market Performance - The China Convertible Bond Index closed at 485.31 points after a morning increase of 0.39% [1][2] - Notable gainers included: - Jia Mei Convertible Bond, which increased by 16.34% - Hua Ti Convertible Bond, which rose by 13.62% - Hui Cheng Convertible Bond, which saw a rise of 10.14% [1][2] - Conversely, the following bonds experienced declines: - Bo Rui Convertible Bond, which fell by 9.47% - Jin Zhong Convertible Bond, which decreased by 4.91% - Rui Da Convertible Bond, which dropped by 2.44% [1][2]

Core Viewpoint - The China Convertible Bond Index experienced a slight decline of 0.07%, closing at 482.61 points on December 15, indicating a mixed performance in the convertible bond market [1]. Group 1: Market Performance - The China Convertible Bond Index fell by 0.07% to 482.61 points [1]. - Notable gainers included Guanzhong Convertible Bond, which rose by 13.39%, Bojun Convertible Bond with a 4.48% increase, and Yake Convertible Bond, which increased by 4.22% [1]. - Conversely, Jiaze Convertible Bond decreased by 5.40%, Yingbo Convertible Bond fell by 3.86%, and Borui Convertible Bond dropped by 3.47% [1].

Core Viewpoint - The Zhongzheng Convertible Bond Index opened with a slight increase of 0.08%, reaching 477.96 points on September 16 [1] Group 1: Market Performance - The top gainers in the convertible bond market included Yuguang Convertible Bond, Borui Convertible Bond, New 23 Convertible Bond, Songsheng Convertible Bond, and Yinlun Convertible Bond, with increases of 6.74%, 4.28%, 3.05%, 1.98%, and 1.97% respectively [1] - The largest decliners were Haitai Convertible Bond, Jiuzhou Turn 2, Luokai Convertible Bond, Aofei Convertible Bond, and Yiwei Convertible Bond, with decreases of 5.02%, 3.76%, 1.71%, 1.42%, and 1.40% respectively [1]

Core Viewpoint - The company, Borui Pharmaceutical, announced that it will not exercise the early redemption rights for its convertible bonds, known as "Borui Convertible Bonds," during the upcoming board meeting scheduled for September 11, 2025 [2]. Group 1 - The fourth session of the company's eleventh board meeting will take place on September 11, 2025 [2]. - The company has decided not to redeem the "Borui Convertible Bonds" early [2].

Group 1 - The subscription result for CapitaLand Commercial REITs (508091) shows a total subscription amount of 146.5 billion [1] - The subscription for the new stock Shichang Co., which was listed on the Beijing Stock Exchange, reached 649.6 billion on the same day [1] - The total idle funds for new stock subscriptions amount to approximately 800 billion, calculated as 146.5 billion + 649.6 billion [1] Group 2 - Shareholders of Jinpu Garden plan to reduce their holdings by no more than 4.58% of the company's shares [1] - The Bo Rui convertible bond will not be forcibly redeemed [2] - The Fangyuan convertible bond will not undergo a downward adjustment [2] Group 3 - The listing of CICC Vipshop Outlet REIT (508082) has occurred [1]

Core Viewpoint - 博瑞生物医药（苏州）股份有限公司 has triggered conditional redemption terms for its convertible bonds due to stock price performance, but has decided not to exercise the early redemption option to protect investor interests [1] Group 1: Redemption Conditions - The company’s stock has met the condition of closing prices being at least 130% of the conversion price (45.16 CNY/share) for 15 out of 30 consecutive trading days from August 22 to September 11, 2025 [1] - The board of directors approved the decision not to redeem the "博瑞转债" early on September 11 [1] Group 2: Future Considerations - The company will not exercise the early redemption right for the next three months (from September 12 to December 11) even if the redemption conditions are met again [1] - No trading of "博瑞转债" has occurred by relevant parties within the six months prior to the satisfaction of the redemption conditions [1]